David C Klonoff Editor

Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He has received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF. Dr. David Kerr is Director of Research and Innovation at Sansum Diabetes Research Institute, Santa Barbara, and Director of Digital Services for the Diabetes Technology Society. Previously he was Consultant Physician in Internal Medicine and Endocrinology at the Bournemouth Diabetes and Endocrine Centre in the UK. His research and innovation continue to focus on the use of technology for diabetes care and also the new area of digital health. He is co-founder of the annual Digital Diabetes Congress and recently launched a major long-term initiative to reduce the burden of diabetes for an underserved population in the United States through the creation of an innovative long-term cohort study (Mil Familias). He is also lead investigator in a program exploring the value of food as medicine through the use of medical prescriptions of vegetables for adults with or at risk of type 2 diabetes (Farming for Life). Dr. Elissa R. Weitzman is Associate Professor of Pediatrics at Harvard Medical School, and of Adolescent/Young Adult Medicine at Boston Children's Hospital. Her research focuses on improving the health of youth, with an emphasis on addressing chronic illness and behavioral health problems. A mixed-methods scientist, Weitzman uses narrative, cohort, and “big data” passive or participatory surveillance methods to illuminate the epidemiology and experience of chronic illness. Recognizing population engagement with digital health tools and online disease communities, she has investigated willingness to share electronic data for research, quantified the quality and safety of online health communities, and tested informatics-enabled models for returning research data to cohorts to drive engagement. Weitzman has a Bachelor’s from Brandeis University, a Masters and Doctorate from the Harvard TH Chan School of Public Health, and has completed post-doctoral training in Medical Ethics and Public Health in Psychiatry at the Harvard Medical School.